15 June 2022 | News
The site is equipped with a 'Zero Liquid Discharge' facility to ensure all liquid waste gets adequately treated in-house and recycled back to utilities
Image credit: www.prnewswire.com
Piramal Pharma's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), has announced that the company's site in Digwal in the state of Telangana has implemented various tools to unlock Active Pharmaceutical Ingredient (API) manufacturing capacity and support client needs in drug development and on-patent projects.
Now, Digwal's R&D capabilities are being further strengthened, with approximately 20 new fume hoods coming online to support services projects. As a result, the site has recently partnered with clients on more than a dozen programmes, including several which have been commercially launched and others that are under registration with the regulator.
The Digwal site is equipped with a 'Zero Liquid Discharge' facility to ensure all liquid waste gets adequately treated in-house and recycled back to utilities. The solvent recovery infrastructure has also been upgraded, resulting in increased distillation efficiency and a reduction in solvent consumption.
In addition to the increased reactor capacity, the Digwal site will benefit from infrastructure upgrades that include a renovated administration block, a new canteen facility, Quality Control lab revamp, and more. The consolidation and creation of a centralised new warehouse for the storage of finished goods that features a warehouse management system (WMS) are currently underway.